INJIZIERBARE SUSPENSIONEN
European patent · EP3565528 · In force
Register entry
- Publication number
- EP3565528
- Application number
- EP18700645
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 9, 2018
- Published
- Nov 13, 2019
- Granted
- Feb 19, 2025
- Protection ends at the latest
- Jan 8, 2038
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 9/10 (2006.01)A61K 47/14 (2017.01)A61K 47/28 (2006.01)A61K 9/16 (2006.01)A61K 31/57 (2006.01)B01D 9/00 (2006.01)C07J 7/00 (2006.01)
- Priority
- SE 1750008 09.01.2017
- PCT application
- PCT/EP2018/050453 09.01.2018
- PCT publication
- WO2018/127601 12.07.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 27, 2026
Change
Published in Swissreg on 27.03.2026
- Dec 31, 2025
Change
Published in Swissreg on 31.12.2025
- Jun 18, 2025
Agent entered
- Representative
- AWA Switzerland Ltd., Case Postale 47, 2800 Delémont
Published in Swissreg on 18.06.2025
- May 21, 2025
Owner
- Owner
- Asarina Pharma AB, Fogdevreten 2, 171 65 Solna, Sweden → Relmada Therapeutics, Inc., 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134, USA
Published in Swissreg on 21.05.2025
- Feb 19, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.02.2025
Parties
Inventor
BRISANDER, Magnus
178 35 Ekerö, SE
HORVATH, Karol
691 52 Karlskoga, SE
NORRLIND, Björn
113 39 Stockholm, SE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.